T. Rowe Price Investment Management
RVMD icon

T. Rowe Price Investment Management’s Revolution Medicines RVMD Stock Holding History

T. Rowe Price Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109M Sell
579,382
-84,665
-13% -$12.4M 0.07% 251
2026
Q1 		$64.6M Sell
664,047
-1,536,329
-70% -$155M 0.04% 314
2025
Q4 		$175M Sell
2,200,376
-2,581,942
-54% -$169M 0.11% 178
2025
Q3 		$223M Buy
4,782,318
+93,020
+2% +$3.64M 0.14% 162
2025
Q2 		$173M Buy
4,689,298
+3,015,869
+180% +$116M 0.11% 199
2025
Q1 		$59.2M Buy
+1,673,429
New +$67.9M 0.04% 364

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Investment Management's RVMD Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Revolution Medicines (RVMD) stake by 13% in Q2 2026, selling an estimated $12.4M and leaving 579,382 shares worth $109M. The position accounts for 0.07% of the portfolio, ranked #251.

T. Rowe Price Investment Management first reported a position in RVMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $223M in Q3 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • T. Rowe Price Investment Management held 579,382 shares of Revolution Medicines worth $109M as of Q2 2026.
  • T. Rowe Price Investment Management sold 84,665 Revolution Medicines shares in Q2 2026, an estimated $12.4M.
  • Revolution Medicines made up 0.07% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #251 holding.
  • T. Rowe Price Investment Management first reported a position in Revolution Medicines in Q1 2025 and has held it in 6 quarters since.
  • T. Rowe Price Investment Management's Revolution Medicines position peaked at $223M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.